While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases
But terpenes might be tempering the process
Several of the common smell-producing compounds in cannabis are associated with analgesic properties, and have attractive safety profiles
It’s the first federal grant to be awarded for psychedelic treatment research in 50 years
Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments
On average, unregulated bud tested had 10%-lower THC than advertised
A study linked self reports of being stoned with time and movement in young adults
The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say
Researchers say their intention isn't to fearmonger, but to educate the public on potential risks
Concerns were raised that cannabis would spike accidents, especially among youth, but data show otherwise
The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas
According to Canadian researchers, cannabis can help people cut the country's most fatal dependency
A 5-year project led by university researchers will study pot as a treatment for opioid use and dependency on methadone or suboxone
In a new study, two popular detection devices never mistook CBD for THC
Surveys from pre- and post-legalization show that heavy consumers are less likely to buy legal Canadian weed due to cost and access
By perpetuating false narratives about fentanyl, lives are put at risk, advocates argue
Researchers are looking at the potential pros and cons of cannabis use on procreative fitness
An international team of scientists discovered that all modern-day pot evolved from 'basal cannabis', first smoked in ancient China more than 12,000 years ago
Current naming conventions have added confusion to the poorly understood genetic background of the thousands of varieties in existence today
The psychedelic movement is no longer about anecdotes, experts say
Results come from the IMAGEN study, a large sample group tracked over time in 4 European countries
Cannabis smokers inhale 'significantly' less harmful chemicals than tobacco smokers, but are still not without some risk
After drinking the psychedelic plant brew together, Jewish-Israeli and Arab-Palestinian participants reported moments of deep connection, unity and oneness
Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA
Aside from impairment testing, Ontario-based Zentrela wants to work with cannabis producers to generate accurate product claims
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
Identifying specific terpene-cannabinoid combinations can create new ways to improve medical therapy, researchers suggest
More alcohol, but not weed, use during youth is associated with thinning in parts of the brain associated with intelligence, impulsivity and risky behaviour
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
The resource-rich country produces less emissions than the US, but it's still a big problem that government isn't tracking and firms don't want to talk about
Canadian provinces are slowly easing strict marketing rules to be on par with alcohol and meet broader public policy goals, U of A prof says
It's essential to test products pre-launch as they can create bad consumer experiences, says Nextleaf Solutions, which just got approved for human trials
Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off
A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy
Maine-based Desert Harvest is working with university researchers to see if its CBD-aloe vera formula can treat pain more safely and effectively than opioids
In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications
With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field
From CBD drivers to stoner rats, legal reform continues to push weed research to an all-time high
Brock University's Michael Armstrong argues Canada's restrictive labelling rules incentivize producers to maximize THC content and minimize price
Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine








































